Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

NCT00001629 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00001629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1997
Completion date
September 30, 2000
Enrollment
49
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, heart failure, congestive, hypertension, myocardial infarction